ArticleNeurosurgical review2025
Integration of 5-ALA fluorescence and intraoperative MRI in awake craniotomy for glioma resection: a six-year retrospective analysis.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gliomas are the most prevalent primary central nervous system tumors, characterized by their infiltrative growth patterns that complicate accurate surgical resection. Awake craniotomy (AC) enhances the extent of resection while minimizing neurological complications. This retrospective study analyzes the integration of 5-aminolevulinic acid (5-ALA) fluorescence-guided surgery and intraoperative magnetic resonance imaging (iMRI) during AC for glioma resection at a single center in Brazil. A retrospective analysis was conducted on 42 adult patients who underwent AC for gliomas with 5-ALA, with or without iMRI, between 2016 and 2022. The study comprehensively details the preoperative planning, intraoperative protocols, and postoperative outcomes. Patients were stratified into two groups based on using iMRI in conjunction with 5-ALA versus 5-ALA only. The mean age of the patients was 42 years (23-71) in the "5-ALA + iMRI" and 50 years (25-75) in the "5-ALA only" group. Glioblastoma was the most common high-grade glioma in both groups. In both groups, gross-total resection was achieved in 66.7% of patients. The "5-ALA only" resulted in a "5-ALA Free" rate of 51.9% of cases compared to 33.3% of the "5-ALA + iMRI" group (p = 1.0). Postoperative complications included transient and persistent deficits, with persistent aphasia in 20% of cases in the "5-ALA + iMRI" group and 18.5% in the "5-ALA only" group. Persistent hemiparesis appeared in 20% of the "5-ALA + iMRI" and 40.7% in the "5-ALA only" group. The median postoperative Karnofsky Performance Score was 90 in both groups, and the median length of hospital stay was 5.5 days and 5 days, respectively. The integration of 5-ALA and iMRI during AC enhances tumor delineation and maximizes the extent of resection, thereby improving surgical outcomes in glioma resection. Although both surgical approaches yield comparable clinical outcomes, the combined "5-ALA + iMRI" group offers specific intraoperative advantages, particularly in achieving complete resection in eloquent areas. Further multi-center studies with larger cohorts are warranted to validate these preliminary findings and explore the long-term benefits of these technologies.
Indexed as
Identifiers
40389778What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.